Generation Bio Co. operates as a biotechnology company. The Company engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases.
$35-35.5 - breaking this level opens the road to target 1: $43 Target 2: 48 is potential if trend is broken
Generation Bio stock is triggering long on both a technical and fundamental bases. Two company insiders (board members) bought the stock in their personal accounts for a total investment of $599,000. Additionally, GBIO is bouncing off it's high-volume areas where buyers have a history of stepping in and accumulating shares. I'm a few days late on this one, but I...
SHORT-TERM: Local divergence on the 4hr and potential hidden bullish divergence on the daily, over a critical support, entry has to be tactical though. (Stock market is volatile right now and not financial advice)
IPO intraday trading strategy idea Generation Bio is an innovative genetic medicine company creating a new class of gene therapy. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long...